Cargando…

Predictive value of alarm symptoms in Rome IV irritable bowel syndrome: A multicenter cross-sectional study

BACKGROUND: Irritable bowel syndrome (IBS) is a common functional bowel disease that shares features with many organic diseases and cannot be accurately diagnosed by symptom-based criteria. Alarm symptoms have long been applied in the clinical diagnosis of IBS. However, no study has explored the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qian, Wei, Zhong-Cao, Liu, Na, Pan, Yang-Lin, Jiang, Xiao-Sa, Tantai, Xin-Xing, Yang, Qi, Yang, Juan, Wang, Jing-Jie, Shang, Lei, Lin, Qiang, Xiao, Cai-Lan, Wang, Jin-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771393/ https://www.ncbi.nlm.nih.gov/pubmed/35097082 http://dx.doi.org/10.12998/wjcc.v10.i2.563

Ejemplares similares

Predictive value of alarm symptoms in patients with Rome IV dyspepsia: A cross-sectional study
por: Wei, Zhong-Cao, et al.
Publicado: (2020)

Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease
por: Wei, Zhongcao, et al.
Publicado: (2020)

Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Impact of Rome IV irritable bowel syndrome on work and activities of daily living
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
por: Ozer, Muhammet, et al.
Publicado: (2020)

Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
por: Fang, Xiu-Cai, et al.
Publicado: (2022)

Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome
por: Paudel, Mukesh Sharma, et al.
Publicado: (2018)

The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III
por: Park, Dong Won, et al.
Publicado: (2010)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros
por: Ghoshal, Uday C
Publicado: (2017)

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
por: Lacy, Brian E., et al.
Publicado: (2017)

Predictors of healthcare-seeking behavior among Chinese patients with irritable bowel syndrome
por: Fan, Wen-Juan, et al.
Publicado: (2017)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Irritable Bowel Syndrome Prevalence among Participants of Woodstock Rock Festival in Poland Based on Rome IV Criteria Questionnaire
por: Palma, Joanna, et al.
Publicado: (2021)

Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar
por: Kovács, Dénes Botond, et al.
Publicado: (2022)

The Relevance of Food Constituents to the Irritable Bowel Syndrome: A Rome IV-Based Prevalence Study Among Medical Students
por: Mujamammi, Ahmed H., et al.
Publicado: (2023)

The Rome Criteria Divides, Distorts and Dilutes the Prevalence of Irritable Bowel Syndrome
por: Gwee, Kok-Ann, et al.
Publicado: (2010)

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
por: WANG, AnJiang, et al.
Publicado: (2008)

Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study
por: Meng, Qiao, et al.
Publicado: (2021)

The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction
por: Amin, Hussein S., et al.
Publicado: (2021)

Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology
por: Wang, Ruo-Hui, et al.
Publicado: (2023)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply
por: Park, Dong Won, et al.
Publicado: (2010)

Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study
por: Lin, Wan-Tzu, et al.
Publicado: (2017)

Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients
por: Anbardan, Sanam Javid, et al.
Publicado: (2012)

Effect of cognitive behavior therapy combined with exercise intervention on the cognitive bias and coping styles of diarrhea-predominant irritable bowel syndrome patients
por: Zhao, Shi-Rui, et al.
Publicado: (2019)

Psychological Features in the Inflammatory Bowel Disease–Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors
por: Petrik, Megan, et al.
Publicado: (2021)

Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria
por: Miwa, Hiroto
Publicado: (2008)

Observations on the Use of Opium in Removing Symptoms Supposed to Be Owing to Morbid Irritability
Publicado: (1785)

Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome
por: Sabaté, Jean-Marc, et al.
Publicado: (2022)

Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome
por: Zhang, Yu, et al.
Publicado: (2019)

Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients
por: Zhang, Hu, et al.
Publicado: (2021)

Farther Observations on the Use of Opium, in Removing Symptoms Supposed to Be Owing to Morbid Irritability
Publicado: (1785)

What Is New in Rome IV
por: Schmulson, Max J, et al.
Publicado: (2017)

The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment
por: Karabulut, Gülcan S, et al.
Publicado: (2013)

Type IV Pilus Shapes a ‘Bubble-Burst’ Pattern Opposing Spatial Intermixing of Two Interacting Bacterial Populations
por: Wang, Miaoxiao, et al.
Publicado: (2022)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
por: Kanazawa, Motoyori, et al.
Publicado: (2015)

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria
por: Mishima, Takayasu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ap8vbr24ir4m9i176l1kkonngr